Zobrazeno 1 - 10 of 697 pro vyhledávání: '"Baker, RA"'
1
Akademický článek
Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies
Autor: Wigal SB, Wigal T, Hobart M, Madera JJ, Baker RA, Kohegyi E, McKinney A, Wilens TE
Publikováno v: Neuropsychiatric Disease and Treatment, Vol Volume 16, Pp 1411-1426 (2020)
Sharon B Wigal,1 Tim Wigal,1 Mary Hobart,2 Jessica J Madera,3 Ross A Baker,3 Eva Kohegyi,3 Anthony McKinney,4 Timothy E Wilens5 1AVIDA Inc., Newport Beach, California, USA; 2Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, Mary
Externí odkaz: https://doaj.org/article/3e6cabdeeaf74eb7b39e551e80cb4f1e
Zobrazit plný text záznamu
2
Akademický článek
Use of the Functioning Assessment Short Test (FAST) in defining functional recovery in bipolar I disorder. Post-hoc analyses of long-term studies of aripiprazole once monthly as maintenance treatment
Autor: Madera J, Such P, Zhang P, Baker RA, Grande I
Publikováno v: Neuropsychiatric Disease and Treatment, Vol Volume 15, Pp 2325-2338 (2019)
Jessica Madera,1 Pedro Such,2 Peter Zhang,1 Ross A Baker,1 Iria Grande31Medical Affairs, Otsuka Pharmaceutical Development and Commercialization Inc, Princeton, NJ, USA; 2Medical Affairs, H. Lundbeck A/S, Valby, Denmark; 3Bipolar and Depression Disor
Externí odkaz: https://doaj.org/article/6250f530d85c46ba80cb813e2ce4bb79
Zobrazit plný text záznamu
3
Akademický článek
Symptomatic stability with aripiprazole once-monthly: efficacy analyses from acute and long-term studies
Autor: Madera JJ, Such P, Zhao C, Baker RA
Publikováno v: Neuropsychiatric Disease and Treatment, Vol Volume 15, Pp 1593-1604 (2019)
Jessica J Madera,1 Pedro Such,2 Cathy Zhao,3 Ross A Baker11Global Medical Affairs, Otsuka Pharmaceutical Development & Commercialization, Inc, Princeton, NJ, USA; 2Medical Affairs Psychiatry, H. Lundbeck A/S, Valby, Denmark; 3Biostatistics, Otsuka Ph
Externí odkaz: https://doaj.org/article/ac66f4f443d1457484217f752a6d9952
Zobrazit plný text záznamu
4
Akademický článek
The effect of aripiprazole once-monthly on personal and social functioning: post hoc analyses of acute and long-term studies
Autor: Peters-Strickland T, Baker RA, Such P, Zhang P, Madera JJ
Publikováno v: Neuropsychiatric Disease and Treatment, Vol Volume 15, Pp 1659-1669 (2019)
Timothy Peters-Strickland,1 Ross A Baker,2 Pedro Such,3 Peter Zhang,4 Jessica J Madera21Global Clinical Development, Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA; 2Global Medical Affairs, Otsuka Pharmaceutical Devel
Externí odkaz: https://doaj.org/article/4b2fc0dc0ff246e390db26409089565d
Zobrazit plný text záznamu
5
Akademický článek
A multicenter, open-label, pilot study evaluating the functionality of an integrated call center for a digital medicine system to optimize monitoring of adherence to oral aripiprazole in adult patients with serious mental illness
Autor: Kopelowicz A, Baker RA, Zhao C, Brewer C, Lawson E, Peters-Strickland T
Publikováno v: Neuropsychiatric Disease and Treatment, Vol Volume 13, Pp 2641-2651 (2017)
Alex Kopelowicz,1 Ross A Baker,2 Cathy Zhao,2 Claudette Brewer,3 Erica Lawson,3 Timothy Peters-Strickland2 1David Geffen School of Medicine, University of California, Los Angeles, CA, 2Otsuka Pharmaceutical Development and Commercialization Inc., Pri
Externí odkaz: https://doaj.org/article/1ca2a42b126d4ded8b8cb9eb22224a61
Zobrazit plný text záznamu
6
Akademický článek
Digital health technology for use in patients with serious mental illness: a systematic review of the literature
Autor: Batra S, Baker RA, Wang T, Forma F, DiBiasi F, Peters-Strickland T
Publikováno v: Medical Devices: Evidence and Research, Vol Volume 10, Pp 237-251 (2017)
Sonal Batra,1 Ross A Baker,2 Tao Wang,3 Felicia Forma,4 Faith DiBiasi,3 Timothy Peters-Strickland5 1Department of Psychiatry, Rutgers Robert Wood Johnson Medical School, Piscataway, 2Global Medical Affairs, Otsuka Pharmaceutical Development and Comme
Externí odkaz: https://doaj.org/article/81c66866313c472a9d99a0a310eb8041
Zobrazit plný text záznamu
7
Akademický článek
Efficacy and safety of aripiprazole once-monthly in obese and nonobese patients with schizophrenia: a post hoc analysis
Autor: De Hert M, Eramo A, Landsberg W, Kostic D, Tsai LF, Baker RA
Publikováno v: Neuropsychiatric Disease and Treatment, Vol 2015, Iss default, Pp 1299-1306 (2015)
Marc De Hert,1 Anna Eramo,2 Wally Landsberg,3 Dusan Kostic,4 Lan-Feng Tsai,5 Ross A Baker4 1Department of Neurosciences, KU Leuven, Belgium; 2Lundbeck LLC, Deerfield, IL, USA; 3Otsuka Pharmaceutical Europe Ltd., Wexham, UK; 4Otsuka Pharmaceutical Dev
Externí odkaz: https://doaj.org/article/7df5b485319d405f9626c74dc9091453
Zobrazit plný text záznamu
9
Usability of a novel digital medicine system in adults with schizophrenia treated with sensor-embedded tablets of aripiprazole
Autor: Peters-Strickland T, Pestreich L, Hatch A, Rohatagi S, Baker RA, Docherty JP, Markovtsova L, Raja P, Weiden PJ, Walling DP
Publikováno v: Neuropsychiatric Disease and Treatment, Vol Volume 12, Pp 2587-2594 (2016)
Timothy Peters-Strickland,1 Linda Pestreich,1 Ainslie Hatch,2 Shashank Rohatagi,1 Ross A Baker,1 John P Docherty,2 Lada Markovtsova,1 Praveen Raja,3 Peter J Weiden,4 David P Walling5 1Otsuka Pharmaceutical Development & Commercialization, Inc., 2ODH,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doajarticles::5a9a149204e383aad8c8051cec3b99f5
https://www.dovepress.com/usability-of-a-novel-digital-medicine-system-in-adults-with-schizophre-peer-reviewed-article-NDT
Zobrazit plný text záznamu
10
y Long-term effectiveness of aripiprazole once-monthly for schizophrenia is maintained in the QUALIFY extension study
Autor: Naber, D, Baker, RA, Eramo, A, Forray, C, Hansen, K, Sapin, C, Peters-Strickland, T, Nylander, A-G, Hertel, P, Schmidt, SN, Loze, J-Y, Potkin, SG
Publikováno v: Naber, D; Baker, RA; Eramo, A; Forray, C; Hansen, K; Sapin, C; et al.(2018). y Long-term effectiveness of aripiprazole once-monthly for schizophrenia is maintained in the QUALIFY extension study. SCHIZOPHRENIA RESEARCH, 192, 205-210. doi: 10.1016/j.schres.2017.04.013. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/8c13n4gn
To evaluate long-term safety and effectiveness of continued treatment with aripiprazole once-monthly 400mg (AOM 400) in patients with schizophrenia.Patients who completed the QUALIFY study (NCT01795547) in the AOM 400 arm were eligible for 6 addition
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::cd1649ef822c244c6ce10f8b07db86a6
http://www.escholarship.org/uc/item/8c13n4gn
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje